At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 70 enrolled
Drug / intervention
sugammadexdrug
Likely dose
sugammadex 0.9 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Deep Neuromuscular Block on Surgical Condition During Laparoscopic Colorectal Surgery
In Brief
A Phase 4 clinical trial evaluating sugammadex for Neuromuscular Blockade. Completed, enrolled 70 participants.
Detailed Summary
This study is a randomized, controlled, double-blinded, and parallel design study. A total 96 patients were randomized to receive a deep block or a moderate block scheduled for elective laparoscopic colorectal surgery. Investigators estimated the proportion of intra-abdominal pressure(IAP) alarm and surgical rating score.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeuromuscular Blockade
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartMar 2015
First PostedOct 2015
Primary CompletionJun 2016
Study CompletionJun 2016
TodayJul 2026
First PostedOct 20, 2015
Enrollment StartMar 24, 2015
Primary CompletionJun 16, 2016
Study CompletionJun 18, 2016
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.7 years ago
Interventions
sugammadexdrug
Maintenance dose of 0.4-0.9 mg/kg/hr rocuronium as continuous infusion during surgery for the maintenance of post tetanic count 1-2 (deep block).